Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide. The best way to shortlist ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Unsurprisingly, my last two columns discussed artificial intelligence (AI), specifically the impact of language models (LMs) ...

Citizen Sleeper 2 features the same compelling sci-fi setting as its predecessor, but some of the new mechanics might be ...

Horizon Kinetics have published their Q4 2024 Commentary. How’d we do? How’d the market do? What to expect now? Click here to ...

Following the $73 billion merger with Praxair completed at the end of October 2018, Linde is now the world's largest producer ...

There is a hierarchy of troubles, a hierarchy that applies to individuals, families, communities and governments. The least ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

Dry told the DDD on Monday that Crafton formed two new committees at the council's last meeting, one to review the city's ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.